Table 3 Performance of DLP in comparative test data set compared to experts (all fundus only, n = 922).
Diseases/conditions | ID | Average expert | Â | DLP | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
F1 | Sensitivity | Specificity | Subset accuracyb,% | F1 | Sensitivity | Specificity | AUC (95% CI) | Subset accuracy, % | |||
Non-referable | 0 | 0.875 | 0.941 | 0.990 |  | 0.989 | 0.977 | 1.000 | 0.9955 (0.9877–1.0000) |  | |
Referable DR | 1 | 0.951 | 0.935 | 0.993 |  | 0.970 | 0.953 | 0.997 | 0.9942 (0.9894–0.9989) |  | |
RVO | 2 | 0.954 | 0.951 | 0.996 |  | 0.970 | 0.976 | 0.996 | 0.9984 (0.9964–1.0000) |  | |
RAO | 3 | 0.942 | 0.929 | 0.999 |  | 1.000 | 1.000 | 1.000 | 1.0000 (1.0000–1.0000) |  | |
Rhegmatogenous RD | 4 | 0.980 | 0.989 | 0.999 |  | 0.971 | 0.971 | 0.999 | 0.9996 (0.9991–1.0000) |  | |
Posterior serous/exudative RD | 5 | 0.955 | 0.941 | 0.999 |  | 0.964 | 1.000 | 0.998 | 0.9989 (0.9976–1.0000) |  | |
Maculopathy | 6 | 0.951 | 0.955 | 0.996 |  | 0.965 | 0.958 | 0.998 | 0.9967 (0.9929–1.0000) |  | |
ERM | 7 | 0.957 | 0.946 | 0.998 |  | 0.962 | 0.981 | 0.997 | 0.9974 (0.9940–1.0000) |  | |
MH | 8 | 0.957 | 0.945 | 0.999 |  | 0.939 | 0.939 | 0.998 | 0.9712 (0.9154–1.0000) |  | |
Pathological myopia | 9 | 0.962 | 0.952 | 0.998 |  | 0.992 | 0.984 | 1.000 | 0.9999 (0.9997–1.0000) |  | |
Optic nerve degeneration | 10 | 0.961 | 0.950 | 0.998 |  | 0.972 | 1.000 | 0.997 | 0.9996 (0.9988–1.0000) |  | |
Severe hypertensive retinopathy | 11 | 0.895 | 0.885 | 0.997 |  | 0.852 | 1.000 | 0.990 | 0.9961 (0.9919–1.0000) |  | |
Disc swelling and elevation | 12 | 0.963 | 0.955 | 0.998 |  | 0.970 | 1.000 | 0.997 | 0.9997 (0.9993–1.0000) |  | |
Dragged disc | 13 | 0.932 | 0.882 | 1.000 |  | 0.970 | 0.941 | 1.000 | 0.9849 (0.9553–1.0000) |  | |
Congenital disc abnormality | 14 | 0.860 | 0.891 | 0.998 |  | 0.952 | 0.909 | 1.000 | 0.9880 (0.9643–1.0000) |  | |
Pigmentary degeneration | 15 | 0.989 | 0.978 | 1.000 |  | 1.000 | 1.000 | 1.000 | 1.0000 (1.0000–1.0000) |  | |
Peripheral retinal degeneration and break | 16 | 0.966 | 0.948 | 1.000 |  | 1.000 | 1.000 | 1.000 | 1.0000 (1.0000–1.0000) |  | |
Myelinated nerve fiber | 17 | 0.996 | 1.000 | 1.000 |  | 1.000 | 1.000 | 1.000 | 1.0000 (1.0000–1.0000) |  | |
Vitreous particles | 18 | 1.000 | 1.000 | 1.000 |  | 0.966 | 1.000 | 0.999 | 1.0000 (1.0000–1.0000) |  | |
Fundus neoplasm | 19 | 0.918 | 0.933 | 0.999 |  | 1.000 | 1.000 | 1.000 | 1.0000 (1.0000–1.0000) |  | |
Hard exudates | 20 | 0.959 | 0.994 | 0.997 |  | 0.946 | 1.000 | 0.995 | 0.9998 (0.9994–1.0000) |  | |
Yellow-white spots/flecks | 21 | 0.931 | 0.926 | 0.995 |  | 0.898 | 0.971 | 0.985 | 0.9929 (0.9868–0.9989) |  | |
Cotton-wool spots | 22 | 0.962 | 0.934 | 0.999 |  | 0.982 | 0.966 | 1.000 | 0.9989 (0.9974–1.0000) |  | |
Vessel tortuosity | 23 | 0.797 | 0.741 | 0.998 |  | 0.867 | 0.765 | 1.000 | 0.9917 (0.9816–1.0000) |  | |
Chorioretinal atrophy/coloboma | 24 | 0.951 | 0.922 | 0.999 |  | 0.958 | 1.000 | 0.995 | 0.9980 (0.9958–1.0000) |  | |
Preretinal hemorrhage | 25 | 0.949 | 0.958 | 0.998 |  | 0.970 | 0.970 | 0.999 | 0.9932 (0.9799–1.0000) |  | |
Fibrosis | 26 | 0.947 | 0.935 | 0.998 |  | 0.976 | 1.000 | 0.998 | 0.9992 (0.9980–1.0000) |  | |
Laser spots | 27 | 0.973 | 0.951 | 1.000 |  | 0.964 | 0.930 | 1.000 | 0.9913 (0.9803–1.0000) |  | |
Silicon oil in eye | 28 | 0.987 | 0.981 | 1.000 |  | 1.000 | 1.000 | 1.000 | 1.0000 (1.0000–1.0000) |  | |
Blur fundus | 29 | 0.833 | 0.750 | 1.000 |  | 0.750 | 0.750 | 0.999 | 0.9499 (0.8525–1.0000) |  | |
Referablea, frequency-weighted average | Â | 0.954 | 0.943 | 0.998 | Â | 0.964 | 0.972 | 0.998 | 0.9964 | Â | |
Total | Â | Â | Â | Â | 92.45 | Â | Â | Â | Â | Â | 92.19 |